CORLUXIN, created in 2011 (United States), from 2 sister brands and 2214 competing brands. The CORLUXIN brand is owned by Corcept Therapeutics, a company listed in New York. CORLUXIN belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Corcept Therapeutics
(CORLUXIN)
over 5 years*
USD 55.78